Edge Medical Executes HKD 70.34 Million Buyback in October, Adding 2.18 Million H-Shares to Treasury

Bulletin Express11-05

Shenzhen Edge Medical Co., Ltd. (Edge Medical) disclosed in its Monthly Return for Equity Issuer that it repurchased 2.18 million H-shares during October 2026, moving the shares into treasury. The buybacks were executed on 15 trading days between 7–30 October at prices ranging from HKD 30.97 to HKD 33.30, with an estimated aggregate consideration of approximately HKD 70.34 million. The implied average repurchase price stands at about HKD 32.26 per share.

As a result, the company’s outstanding H-share count (excluding treasury shares) fell 0.67% to 323.32 million by month-end, while treasury shares rose to 4.44 million. Total issued H-shares remained unchanged at 327.76 million, indicating that no cancellations have yet occurred.

Edge Medical’s overall registered share capital was steady at RMB 391.88 million, comprising 327.76 million H-shares and 64.12 million unlisted domestic shares, each with a par value of RMB 1.

The company confirmed it continued to satisfy the Hong Kong Main Board’s minimum 15% public-float requirement as of 31 October 2026. No new share options, warrants, or convertible securities were issued, and no other equity-linked instruments were outstanding during the period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment